Efficacy and tolerability of high oral doses of Levetiracetam in children with epilepsy

Epilepsy Research

Volumn 91, Issue 1, 2010, Pages 101-105

  Obeid, Makram ^a   Pong, Amanda W ^a  

^a College of Physicians and Surgeons Columbia University ^*  (United States)

Author keywords

Epilepsy syndrome; Levetiracetam; Seizure

Indexed keywords

ETIRACETAM;

ADOLESCENT; ADULT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERACTIVITY; IRRITABILITY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADOLESCENT; AGE FACTORS; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; MENTAL DISORDERS; PIRACETAM; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956012067     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.06.009     Document Type: Article

References (11)

1. Collins J.J., Tudor C., Leonard J.M., Chuck G., Franz D.N. Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial. J. Child Neurol. 2006, 21:53-57.
2. Depositario-Cabacar D.T., Peters J.M., Pong A.W., Roth J., Rotenberg A., Riviello J.J., Takeoka M. High-dose intravenous levetiracetam for acute seizure exacerbation in children with intractable epilepsy. Epilepsia 2010.
3. Grant R., Shorvon S.D. Efficacy and tolerability of 1000-4000mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy. Epilepsy Res. 2000, 42:89-95.
4. Major P., Greenberg E., Khan A., Thiele E.A. Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results. Epilepsy Behav. 2008, 13:557-559.
5. Mandelbaum D.E., Bunch M., Kugler S.L., Venkatasubramanian A., Wollack J.B. Efficacy of levetiracetam at 12 months in children classified by seizure type, cognitive status, and previous anticonvulsant drug use. J. Child Neurol. 2005, 20:590-594.
6. Patsalos P.N. Clinical pharmacokinetics of levetiracetam. Clin. Pharmacokinet. 2004, 43:707-724.
7. Pellock J.M., Appleton R. Use of new antiepileptic drugs in the treatment of childhood epilepsy. Epilepsia 1999, 40(Suppl. 6):S29-S38. (discussion S73-S74).
8. Pellock J.M., Glauser T.A., Bebin E.M., Fountain N.B., Ritter F.J., Coupez R.M., Shields W.D. Pharmacokinetic study of levetiracetam in children. Epilepsia 2001, 42:1574-1579.
9. Pina-Garza J.E., Nordli D.R., Rating D., Yang H., Schiemann-Delgado J., Duncan B. Levetiracetam N01009 Study Group, Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia 2009, 50:1141-1149.
10. Rosenfeld W.E., Benbadis S., Edrich P., Tassinari C.A., Hirsch E. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies. Epilepsy Res. 2009, 85:72-80.
11. Wheless J.W. Levetiracetam in the treatment of childhood epilepsy. Neuropsychiatr. Dis. Treat. 2007, 3:409-421.